Pathological mechanisms and disease progression of multiple sclerosis: therapeutic implications
Drugs Today (Barc)
.
2002 Jan;38(1):17-29.
doi: 10.1358/dot.2002.38.1.660507.
Authors
Carl Bjartmar
1
,
Robert J Fox
Affiliation
1
Department of Neurosciences, Lerner Research Institute, Cleveland, Ohio, USA.
PMID:
12532182
DOI:
10.1358/dot.2002.38.1.660507
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Review
MeSH terms
Atrophy / pathology
Disease Progression
Humans
Multiple Sclerosis / drug therapy*
Multiple Sclerosis / immunology
Multiple Sclerosis / pathology*